Project Details
| Short title | 90301900NSC2001 |
|---|---|
| Acronym | CONVERGE |
| Status | Active |
| Effective start/end date | 17/07/25 → 17/07/30 |
CTU: A Phase 2, randomized, open-label, active-controlled study of JNJ-90301900 in combination with chemoradiation followed by durvalumab in locally advanced and unresectable Stage III non-small cell lung cancer
- Saghaie, Tajalli (Primary Chief Investigator)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Lawrie, Angus (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research